Delivering On the Promise of Glioblastoma Immunotherapy

Time: 12:30 pm
day: Conference Day Two


  • Local delivery in the brain eliminates the need to cross the BBB, opening new
    GBM treatment opportunities
  • Combination therapy that can educate the immune system and generate
    immune memory is required to obtain long-lasting anti-tumor responses
  • Sustained delivery of the therapy is required to bridge the innate and adaptive
    immune responses to obtain immune memory